Decision Nº M/13/024 from Competition and Consumer Protection Commission, 2013-09-19

Date19 September 2013
Decision NumberM/13/024
PartiesKinetic Concepts Inc.,Systagenix
StatusCleared (Phase 1)
M/13/024 – KCI/Systagenix
DETERMINATION OF MERGER NOTIFICATION M/13/024 -
KCI/Systagenix
Section 21 of the Competition Act 2002
Proposed acquisition by Kinetic Concepts Inc. of sole control of
Systagenix Wound Management (US) I nc. and Systagenix Wound
Management Mezz B.V.
Dated 19 September 2013
Introduction
1. On 23 August 2013, in accordance wi th section 18 of the Competi tion
Act 2002 (“the Act”), the Competi tion Authority (“the Authority”)
received a noti fication of a proposed acquisition whereby Kinetic
Concepts, Inc. (“KCI”), a portfolio company of Apax Partners LLP
(“Apax”), would acquire sole contr ol of Systagenix Wound Management
(US) Inc. and Systagen ix Wound Management Mezz B.V. (together
“Systagenix”).
The Undertakings Involved
Apax
2. Apax is a limited liability partnersh ip in the United Kingdom and the
parent of a number of companies which provide in vestment advisory
services to private equi ty funds investing in a range of ind ustry sectors
primarily in Europe. Apax is not cont rolled by any single individ ual or
entity. Di rectly or indi rectly, Apax acts as the lead investment advisor
for private equity funds, and exercises decisive influence over equity
investments made by such funds.
3. In addition to KCI, Apax controls the following portfolio companies
which are active in the State:
New Look Group, a retailer of fashion apparel;
ALM, a publisher serving the legal industry;
Top Right Group, a provider of media services;
Epicor, a provider of business software;
iGate, a provider of IT and business process outsourcing
services; and
Trader Media, automotive classified advertising through
magazines and online.

To continue reading

Request your trial

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT